Europe Clinical Trial Management System Market size to amass significant gains by 2026

The research report on Europe Clinical Trial Management System Market provides an in-depth analysis of this industry with pivotal details subject to its overall position in the global landscape and its applications across various end-user sectors.

Request a sample of this research report @

As per the report, Europe clinical trial management system market value was valued at USD 362.9 million in 2019 and is expected to witness 14.3% CAGR from 2019 to 2026. In addition to this, the study also encompasses crucial information on the current market scenario, evolving technologies, widespread competitive landscape, growth prospects, industry tactics, and vivid market segmentations.

Moreover, the report also offers insight to various factors that would potentially drive the growth graph of the industry over the foreseeable time period, along with delivering minute details on the ongoing trends that the Europe clinical trial management system industry is characterized by. The Europe clinical trial management system market, as per given report, is fragmented on basis of regions, and competitive landscape.

Clinical research organizations segment accounted for around 25% revenue share in 2019. The increased number of outsourcing of clinical trials by various pharmaceutical companies will drive the segment growth. Moreover, growing R&D expenditure by clinical research industries is further expected to boost the CTMS market growth.

 The overall Europe clinical trial management system industry is diversified into various regions and economies including Europe and its complete analysis has been enclosed in the report as well. It lays focus on various factors supporting the growth of regional markets in tandem with trending growth opportunities existing in every region, their individual growth rates, technologies being used, stringent regulatory reforms, and much more.

Europe clinical trial management systems market was valued at over USD 360 million in 2019. Europe is preferred by many pharmaceutical companies for conducting clinical trials. This is attributed to high enrolment rates, convenient access to the patient population, centralized healthcare systems and skilled investigators. Furthermore, population size, cost of medical research and fast patient recruitment are the parameters augmenting business growth of clinical trials management system in Europe region.

 Taking into account the competitive landscape, Europe clinical trial management system industry is highly consolidated and boasts of presence of companies like Bioclinica, Bio-Optronics, DSG, DataTrak International, Forte, MasterControl, Medidata Solutions, Merge Healthcare (IBM Watson Health), OmniComm Systems, Oracle, PAREXEL International, and Veeva Systems other industry participants. The report includes details on sales spectrum of each of these firms, their strategies to sustain their position in the market, individual company profiles and market share, and position in the overall ecosystem.

Table of content:

Chapter 4.         Europe Clinical Trial Management System Market, By Component

4.1.   Key trends in Europe clinical trial management system, by component

4.2.   Software

4.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.   Hardware

4.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.   Services

4.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

 Request for an in-depth table of contents for this report @